Wilke T, Ahrendt P, Schwartz D, Linder R, Ahrens S, Verheyen F. Incidence and prevalence of type 2 diabetes mellitus in Germany: an analysis based on 5.43 million patients. Dtsch Med Wochenschr. 2013;138(3):69-75.

Wilke T, Groth A, Müller S, Verheyen F, Linder R, Pfannkuche M, Maywald U,  Bauersachs R, Breithardt G. Prevalence and Incidence of Atrial Fibrillation: An Analysis Based on 8.3 Million Patients. Value in Health. 2012;15(4):A115–A116.

Wilke T, Müller S, Bauersachs R, Breithardt G. The influence of disease-specific symptoms on the health-related quality of life in patients with atrial fibrillation. 2012;15(7):A379.

Wilke T, Müller S. The quality of anticoagulation therapy in patients with atrial fibrillation. Value in Health. 2012;15(4):A128.

Wilke T, Groth A, Müller S, Ahrendt P, Schwartz D, Linder R, Ahrens S, Verheyen F. Prevalence and Incidence of Type 2 Diabetes Mellitus: An Analysis Based on 5.4 Million Patients. Value in Health. 2012;15(4):A174-A175.

Wilke T, Groth A, Müller S, Pfannkuche M, Verheyen F, Linder R, Maywald U, Kohlmann T, Feng YS, Breithardt G, Bauersachs R. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients. Thrombosis & Haemostasis. 2012;107(6):1009–1194.

Wilke T, Müller S, Morisky D.E. Toward Identifying the Causes and Combinations of Causes Increasing the Risks of Nonadherence to Medical Regimens: Combined Results of Two German Self-Report Surveys. Value in Health. 2011;14(8):1092–1100.

Müller S, Wilke T, Pfannkuche M, Meßer I, Kurth A, Merk H, Steinfeldt F, Ganzer D, Perka C. Patientenpfade in der Thromboseprophylaxe nach Hüft- und Kniegelenkersatz. Der Orthopäde. 2011;40(7):585-590.

Wilke T, Müller S, Groth A, Maywald U, Verheyen F. Anforderungen an ein effektives Adherence-Persistence-Programm am Beispiel von oralen Antidiabetika bei Diabetes mellitus Typ 2-Patienten. Gesundheitsökonomie & Qualitätsmanagement. 2011;16(5): 274-291.

Wilke T, Greinacher A. Hospital-specific calculation of heparin-induced thrombocytopenia costs: a review. J Lab Med 2011;35(1); S:35-43.